Churchill Capital Corp XI
Key Highlights
- Raised $414 million in IPO to target high-growth private companies
- Led by experienced management team with a track record of successful SPAC exits
- Protected trust structure ensures capital return if no merger occurs within 24 months
- Targeting high-growth sectors including technology, industrial services, and healthcare
Financial Analysis
Churchill Capital Corp XI Annual Report - How They Did This Year
I’m putting together a guide to help you understand how Churchill Capital Corp XI performed this past year. Think of this as a plain-English breakdown of what’s happening under the hood, without the confusing Wall Street jargon.
1. What does this company do?
Churchill Capital Corp XI is a "blank check" company, also known as a Special Purpose Acquisition Company (SPAC). It doesn’t make products or provide services. Instead, it raised $414 million from investors through an IPO. Its sole purpose is to find a private company and take it public through a merger. As of December 31, 2025, the company is in the "hunting" phase. It holds your money in a trust while it looks for a business worth between $1 billion and $5 billion.
2. Financial performance
Because it is a shell company, it doesn’t earn profit from business operations. Its only income comes from interest on the $414 million held in its trust account. This money is invested in safe, short-term U.S. government securities. The company pays for legal, accounting, and regulatory costs using a $5 million investment provided by its sponsor, Churchill Sponsor XI, LLC.
3. Major wins and challenges
The company successfully launched on the Nasdaq on December 18, 2025, under the ticker "CCXI." It raised $414 million by selling 41.4 million units at $10.00 each. Each unit includes one share of stock and half of a warrant, which allows you to buy more shares later at $11.50. The company has 24 months to finish a merger. If it fails to do so by December 18, 2027, it must return the money in the trust to shareholders.
4. Financial health
As of December 31, 2025, the company keeps $414 million in a protected trust account. This ensures the money is available for a future deal or to pay you back if no deal happens. Michael Klein and Jay Taragin lead the company, supported by a team of former top executives who help evaluate potential businesses. The $5 million from the sponsor covers the day-to-day costs of finding and negotiating a deal.
5. Key risks to watch
Investing in a SPAC is a bet on the management team’s ability to find a good deal. Key risks include:
- The "Bad Deal" Risk: The company might merge with a business that performs poorly, causing the stock price to drop below the $10.00 redemption value.
- The "No Deal" Risk: If the team finds no target within 24 months, the company dissolves. You get your money back, but you miss out on other market gains.
- Management Focus: The leaders have other business interests, which may limit the time they spend on this company.
- Market Sensitivity: The stock price can swing based on how investors feel about SPACs. If the company fails to meet Nasdaq rules, it could be delisted, making it harder to sell your shares.
6. Future outlook
The team is currently searching for high-growth companies in technology, industrial services, and healthcare. They are looking for businesses with strong cash flow and a competitive edge. They hope to use the "Churchill" brand—known for taking companies like Lucid Motors public—to attract high-quality private businesses.
7. Important Note for Investors
Because this is a SPAC, the stock price depends on rumors and speculation about a future deal. If the market loses faith in the team, the stock might trade for less than the cash held in the trust. If rumors of a great merger start, the stock might trade for more than the cash value. If you are considering an investment, be mindful of the current share price relative to the $10.00 cash-per-share value held in the trust.
Risk Factors
- Potential for poor merger performance leading to stock price decline below $10.00
- Risk of dissolution if no suitable acquisition target is identified within 24 months
- Management team's focus is split across multiple business interests
- Market volatility and sensitivity to SPAC-specific investor sentiment
Why This Matters
Stockadora is highlighting this report because Churchill Capital Corp XI represents a critical 'blank check' opportunity at the start of its 24-month clock. For investors, this is a pure play on management's ability to replicate past successes like Lucid Motors.
We surfaced this because the company's current 'hunting' phase offers a unique entry point. Understanding the $10.00 redemption floor versus the potential for merger-driven upside is essential for anyone looking to navigate the current SPAC landscape.
Financial Metrics
Learn More
About This Analysis
AI-powered summary derived from the original SEC filing.
Document Information
SEC Filing
View Original DocumentAnalysis Processed
March 27, 2026 at 02:12 AM
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.